News
-
-
PRESS RELEASE
Alzchem Group AG achieves record year in 2025: once again, record figures for sales and EBITDA thanks to proven focus on specialty chemicals and ingredients
Alzchem Group AG achieves record year in 2025 with increased sales and EBITDA, driven by specialty chemicals focus. Company plans dividend increase and forecasts further growth in 2026 -
-
PRESS RELEASE
Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Alzchem Group AG extends Management Board contracts of Andreas Niedermaier and Andreas Lösler ahead of schedule to ensure continuity and future growth -
-
-
-
PRESS RELEASE
Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors
Alzchem Group AG approves EUR 120 million investments for capacity expansion in sports, food, and health sectors to strengthen market position. Focus on premium segment and new applications -
-
PRESS RELEASE
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products
Alzchem Group AG approves 120 million euros investment program for capacity expansion in creatine products, targeting health, nutrition, and pharmaceutical applications